Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Alcidion Group Limited ( (AU:ALC) ) just unveiled an announcement.
Alcidion Group Limited, a healthcare IT specialist focused on clinical decision support and interoperability, has built its offering around the Miya Precision platform to help hospitals and healthcare organisations improve patient outcomes. The company operates across Australia, New Zealand and the United Kingdom, combining software and technical services to deliver integrated digital health solutions at scale.
Alcidion announced that it will release its full-year financial results for FY26 on 19 August 2026 and will host a live investor webcast the same day, led by its CEO and CFO. The webcast will cover operational and commercial highlights for the year and include a Q&A session, underscoring the company’s engagement with investors and providing stakeholders with insight into its performance and strategic progress.
The most recent analyst rating on (AU:ALC) stock is a Buy
with a A$0.15 price target.
To see the full list of analyst forecasts on Alcidion Group Limited stock,
see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a healthcare technology company that develops proactive, smart and intuitive software solutions to improve the efficiency and quality of patient care. Its flagship platform, Miya Precision, aggregates clinical data into centralised dashboards, supports interoperability, facilitates communication and task management, and delivers clinical decision support at the point of care.
The company offers a complementary suite of software products and technical services to hospitals and healthcare organisations in Australia, New Zealand and the United Kingdom. Since listing on the ASX in 2016, Alcidion has expanded through acquisitions and now operates at scale across these markets, with further international growth planned as it leverages more than 25 years of healthcare experience.
Average Trading Volume: 830,431
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$122.3M
Learn more about ALC stock on TipRanks’ Stock Analysis page.